Carcinogen in Zantac and Generics Triggers FDA, EU Probes
An employee in protective clothing uses a pair of tweezers as glass vials move along a conveyor on the production line at a pharmaceutical plant in Guangzhou, China. (Photographer: Qilai Shen/Bloomberg)

Carcinogen in Zantac and Generics Triggers FDA, EU Probes

(Bloomberg) -- Global health regulators sounded a coordinated alarm about the possibility that a stomach drug taken by millions of people could be tainted with the same cancer-causing agent that ha...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.